You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
The advisory panel wasn't convinced that a clinical trial proved that early switching to camizestrant improved long-term survival rates.
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.